Operative Site Infection (Surgical Site Infection) – A Complete Patient Guide

Overview

Operative site infection (OSI), more commonly called a surgical site infection (SSI), is an infection that occurs at or near the incision or the area that was operated on within 30 days of the procedure (or up to 90 days if an implant is placed). SSIs are among the most common healthcare‑associated infections worldwide.

• Prevalence: According to the Centers for Disease Control and Prevention (CDC), SSIs account for approximately 20 % of all hospital‑acquired infections, affecting 2–5 % of patients undergoing clean or clean‑contaminated surgeries in the United States.¹
• Population affected: All patients who have had an operation are at risk, but the incidence is higher in:
  • Adults over 65 years
  • People with diabetes, obesity, or immune compromise
  • Patients undergoing colorectal, orthopedic, or cardiac surgery
• Impact: SSIs increase hospital stay by an average of 7‑10 days, raise costs by $20,000–$30,000 per case, and are associated with a 2‑3 % increase in postoperative mortality.²

Symptoms

Symptoms may appear within a few days after surgery or up to several weeks later. The presentation depends on the depth of infection (superficial, deep incisional, or organ/space).

• Redness (erythema) around the incision: Diffuse or localized, often spreading outward.
• Swelling (edema): May feel warm to the touch.
• Pain or tenderness: New or worsening pain at the site, especially when moving the affected area.
• Heat: The skin feels hotter than surrounding tissue.
• Pus or discharge: Yellow, green, or bloody fluid may ooze from the wound.
• Foul odor: Indicates bacterial overgrowth, particularly with anaerobes.
• Dehiscence (wound reopening): The incision edges separate.
• Fever ≥ 38 °C (100.4 °F): Systemic sign of infection.
• Chills or rigors: Often accompany fever.
• Elevated heart rate (tachycardia): > 100 bpm may signal systemic infection.
• Unexplained fatigue or malaise: Particularly if infection spreads.
• Signs of deeper infection (deep incisional or organ/space): Persistent abdominal pain after abdominal surgery, difficulty moving a limb after orthopedic surgery, or drainage from a drain tube.

Causes and Risk Factors

How an Operative Site Infection Develops

SSIs result from the introduction of microorganisms into the wound during or after surgery. Common pathways include:

• Intra‑operative contamination: Bacteria from the patient’s skin, gastrointestinal tract, or the operating room environment.
• Post‑operative colonization: Through wound dressings, drains, or hematogenous spread from another infection site.

Common Causative Organisms

• Staphylococcus aureus (including MRSA) – most frequent in skin‑contaminated procedures.
• Streptococcus pyogenes – often in clean surgeries.
• Enterococcus spp. – common in colorectal procedures.
• Gram‑negative rods (e.g., E. coli, Klebsiella) – typical in abdominal and pelvic surgeries.
• Anaerobic bacteria (e.g., Bacteroides fragilis) – associated with deep intra‑abdominal infections.

Risk Factors

Understanding personal and procedural risk factors helps guide preventive strategies.

• Patient‑related
  • Age > 65 years
  • Diabetes mellitus (especially poorly controlled HbA1c > 7 %)
  • Obesity (BMI ≥ 30 kg/m²)
  • Smoking or recent tobacco use
  • Immunosuppression (e.g., corticosteroids, chemotherapy, HIV)
  • Malnutrition or low serum albumin
  • Pre‑existing skin colonization with MRSA or other resistant organisms
• Procedure‑related
  • Emergency surgery (limited time for prophylaxis)
  • Prolonged operative time (> 2 hours)
  • Inadequate skin preparation or breach of sterile technique
  • Use of implants or prosthetic material
  • Contaminated or dirty surgical field (e.g., bowel surgery)
  • Post‑operative drains, catheters, or wound vacuums left in place > 48 hours

Diagnosis

Diagnosis is primarily clinical, supported by laboratory and imaging studies when needed.

Clinical Criteria (CDC)

• Purulent drainage from the incision
• Positive culture from a wound swab or aspirate
• Signs of infection (pain, redness, swelling) plus incision is purposely opened by a surgeon
• Diagnosis of a SSI by a clinician based on documented clinical findings

Laboratory Tests

• Complete blood count (CBC): Elevated white blood cells (WBC) suggest infection.
• C‑reactive protein (CRP) & ESR: Inflammatory markers; useful for monitoring response to therapy.
• Wound culture: Swab or tissue sample for aerobic and anaerobic bacteria; essential for targeted antibiotics.
• Blood cultures: When systemic signs (fever, sepsis) are present.

Imaging

• Ultrasound: Detects fluid collections or abscesses near the wound.
• CT scan (with contrast): Gold standard for deep or organ/space infections, especially in abdominal or chest surgery.
• MRI: Helpful for orthopedic hardware infections and soft‑tissue assessment.

Other Diagnostic Tools

• Probe-to‑bone test: For suspected bone involvement in orthopedic procedures.
• Procalcitonin: May help differentiate bacterial infection from inflammation, though not routinely required.

Treatment Options

General Principles

• Prompt identification and source control.
• Empiric antimicrobial therapy started within 24 hours of suspicion.
• Tailor antibiotics based on culture results and susceptibility testing.
• Address any modifiable risk factors (e.g., glucose control, smoking cessation).

Antibiotic Therapy

Scenario	Empiric Choice (US)	Duration
Clean/clean‑contaminated surgery, MSSA risk	Cephalexin 1 g IV q8h or Cefazolin 2 g IV q8h	3‑5 days (if no prosthesis)
MRSA risk (history, colonization)	Vancomycin 15 mg/kg IV q12h or Daptomycin 6 mg/kg IV q24h	5‑7 days
Gram‑negative/anaerobic coverage (colon surgery)	Piperacillin‑tazobactam 4.5 g IV q6h	5‑7 days
Allergy to β‑lactams	Clindamycin 900 mg IV q8h ± Aztreonam 2 g IV q8h	5‑7 days

Duration may be extended to 2‑6 weeks for infections involving implants or hardware, as recommended by the Infectious Diseases Society of America (IDSA).³

Surgical Interventions

• Incision and drainage (I&D): Mainstay for abscesses or purulent collections.
• Debridement and lavage: Removal of necrotic tissue; may be repeated.
• Implant removal or exchange: Considered when prosthetic material is infected and cannot be sterilized.
• Negative pressure wound therapy (NPWT): Promotes granulation and reduces edema.
• Re‑closure after infection control: Delayed primary closure once the wound is clean.

Adjunctive Measures

• Optimizing glycemic control (target <140 mg/dL fasting, <180 mg/dL post‑prandial).
• Analgesia for pain control (acetaminophen, NSAIDs unless contraindicated).
• Nutrition support – high‑protein diet, consider supplements if albumin <3.5 g/dL.
• Smoking cessation aids (nicotine replacement, counseling).

Living with Operative Site Infection

Recovery can be challenging, but following these daily strategies can improve outcomes and comfort.

• Wound care: Change dressings as instructed, keep the area clean, and avoid soaking without medical approval.
• Medication adherence: Complete the full antibiotic course even if symptoms improve.
• Monitor signs: Record temperature twice daily; watch for increasing redness, swelling, or new drainage.
• Activity level: Follow surgeon’s guidance—usually light walking is encouraged, but avoid heavy lifting or strain on the surgical site.
• Hydration and nutrition: Aim for 2–3 L of water per day and protein‑rich meals (lean meat, beans, dairy, eggs).
• Blood sugar control: For diabetics, check glucose 4–6 times daily and adjust insulin per provider’s plan.
• Stress management: Use deep‑breathing, short walks, or meditation to reduce cortisol, which can impair healing.
• Follow‑up appointments: Keep all wound checks; early detection of recurrence is key.

Prevention

Most SSIs are preventable with evidence‑based measures before, during, and after surgery.

Pre‑operative

• Screen for and decolonize MRSA carriers (nasal mupirocin ointment + chlorhexidine wash).
• Manage diabetes; aim for HbA1c < 7 % before elective procedures.
• Encourage smoking cessation at least 4 weeks prior.
• Administer appropriate prophylactic antibiotics within 60 minutes before incision (or 120 minutes for vancomycin).
• Shave only with electric clippers immediately before surgery, if needed.

Intra‑operative

• Strict aseptic technique, including surgical hand scrub and sterile gloves.
• Maintain normothermia (core temp ≥ 36 °C) – use warming blankets.
• Control blood glucose intra‑operatively (< 180 mg/dL).
• Limit operative time; consider two‑team approach for very long cases.
• Use sterile barriers for implants and sutures.

Post‑operative

• Keep dressings dry and intact for the recommended period.
• Remove drains and catheters as soon as clinically feasible.
• Continue appropriate antibiotic prophylaxis only if indicated (e.g., prosthetic joint surgery).
• Educate patients on wound care, signs of infection, and when to call the surgical team.

Complications

If an SSI is not promptly treated, several serious sequelae may develop.

• Sepsis and septic shock: Systemic infection leading to organ failure; mortality up to 30 % in severe cases.
• Chronic wound or non‑healing incision: May require reconstructive surgery.
• Implant failure or prosthetic joint loss: Necessitates removal and possible re‑implantation.
• Hospital readmission: Average cost per readmission > $15,000.
• Functional impairment: Prolonged immobilization can cause muscle atrophy, joint stiffness, or decreased pulmonary function.
• Scarring and cosmetic concerns: May affect body image, especially after abdominal or facial procedures.
• Antibiotic resistance: Inadequate treatment can select for multidrug‑resistant organisms.

When to Seek Emergency Care

---

Sources: 1. CDC. Surgical Site Infection (SSI) Event. 2023. cdc.gov.
2. Anderson DJ, et al. “The Burden of Healthcare‑Associated Infections in U.S. Hospitals.” CDC Surveillance Report, 2022.
3. Mangram AJ, et al. “Guideline for Prevention of Surgical Site Infection, 2017 Update.” Infectious Diseases Society of America (IDSA).
Additional information adapted from Mayo Clinic, WHO, and Cleveland Clinic guidelines.